Studies On The New Drug Innovation's Strategy Of Pharmaceutical Companies In China

Name; JIANG YI (Pharmacy management) Supervisors:Prof. Kaishun BiNew drug innovation is one of the key factors to pushing the development of national pharmaceutical industry. All over the world, especially developed countries give high priority on the innovation of new drugs. However, as the fund and the level of scientific research is too limited, for years the research of drugs in China depends on copying same drugs made abroad. The low level repeating on medical research is the outstanding issue that puzzles the health of pharmaceutical industry in China. Therefore, timely research and discuss on the development strategy of new drug innovation in pharmaceutical companies of China will benefit improving the general level and international competitiveness of medical field research in China and will speed up the changes from pharmaceutical big country to strong one.According to the currently issues existing in the new drug research in Chinese pharmaceutical companies, it's important to find out the factors and raise the best solutions base on the general analysis on the current new drug research. The research contents are as follows:1. This article proposed the new ideas to development strategy research on new drug companies in China base on the internal and external (environment) factors, which influence on the innovation of our pharmaceutical companies. It researches the current and the features of new drug innovation in China drug companies and the ones in developed countries. And it discusses pharmaceutical development strategy on different types of drug companies. So far, there is no R & D industry chain founded starting from new drug screening researching. The R & D funding is too low and new drugs that have self intellectual property are just a few. Most products are copied ones, which are lack of international competitiveness. According to this status, the new drug innovation should make clear the research direction, complete the internal management, change the development mode, broaden the financing channels, and strengthen the international corporations; 2. This article analyzes the advantages and disadvantages of the current status of new drugs innovation development and outsourcing industry development, then raises the point of pharmaceutical outsourcing companies are conducive to the new drug innovation of Chinese drug companies;3. Drugs companies'new drug innovation strategy also needs the general management of the government, industry base and pharmaceutical market's guarantee to works efficiently. The innovation system leaded by the government, namely officer, produce, study, research, serve, fund, to improve the development of the industry and speed up the steps of new drugs innovation; Full feasibility pharmaceutical industry base, healthy pharmaceutical market, which are promoting with new drug innovation each other. Base on the analysis on the SWOT of China new drug innovation, it points the specific strategy structure and the direction of development.